DSM to acquire Polymer Technology Group

Amsterdam-based Royal DSM has inked a deal to buy the Polymer Technology Group in Berkeley, CA, making it a world leader in polymers for biomedical research. The financial details were not disclosed, but PTG "expects to exceed USD $40 million in net sales with above-average operating profit margin."

"Through the acquisition of PTG, DSM Biomedical gains a leading global position in the fast-growing biomedical materials market," says Steve Hartig, president of DSM. "Our collective technology in combination with our expanded geographical and customer base will help us to develop a unique portfolio of products for the medical device industry. This will have immediate benefit to PTG's customers."

- check out the press release

Related Article:
Polymers show promise in lab-on-a-chip tech

Suggested Articles

More than half of the participants met the primary endpoint, teeing Sanofi up to file for FDA approval of the complement C1s inhibitor.

Cellarity is combining artificial intelligence, a protein discovery platform and what it calls “network biology” in a new drug discovery approach.

Bluebird bio offered the first glimpse of how its CAR-T follow-up is working in multiple myeloma patients who have tried several other treatments.